202 related articles for article (PubMed ID: 32987028)
21. Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.
Hatting M; Spannbauer M; Peng J; Al Masaoudi M; Sellge G; Nevzorova YA; Gassler N; Liedtke C; Cubero FJ; Trautwein C
Cell Death Dis; 2015 Mar; 6(3):e1667. PubMed ID: 25741592
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
Streetz KL; Tacke F; Leifeld L; Wüstefeld T; Graw A; Klein C; Kamino K; Spengler U; Kreipe H; Kubicka S; Müller W; Manns MP; Trautwein C
Hepatology; 2003 Jul; 38(1):218-29. PubMed ID: 12830005
[TBL] [Abstract][Full Text] [Related]
23. T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infection.
Fasnacht N; Greweling MC; Bollati-Fogolín M; Schippers A; Müller W
Eur J Immunol; 2009 Aug; 39(8):2173-83. PubMed ID: 19593768
[TBL] [Abstract][Full Text] [Related]
24. LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling.
Greenhill CJ; Gould J; Ernst M; Jarnicki A; Hertzog PJ; Mansell A; Jenkins BJ
Immunol Cell Biol; 2012 May; 90(5):559-63. PubMed ID: 21670738
[TBL] [Abstract][Full Text] [Related]
25. STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression.
Makino Y; Hikita H; Kato S; Sugiyama M; Shigekawa M; Sakamoto T; Sasaki Y; Murai K; Sakane S; Kodama T; Sakamori R; Kobayashi S; Eguchi H; Takemura N; Kokudo N; Yokoi H; Mukoyama M; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2023; 15(1):99-119. PubMed ID: 36210625
[TBL] [Abstract][Full Text] [Related]
26. Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice.
Ruwanpura SM; McLeod L; Miller A; Jones J; Vlahos R; Ramm G; Longano A; Bardin PG; Bozinovski S; Anderson GP; Jenkins BJ
Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(7):L627-39. PubMed ID: 22268122
[TBL] [Abstract][Full Text] [Related]
27. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
28. IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models.
Carbonaro M; Wang K; Huang H; Frleta D; Patel A; Pennington A; Desclaux M; Moller-Tank S; Grindley J; Altarejos J; Zhong J; Polites G; Poueymirou W; Jaspers S; Kyratsous C; Zambrowicz B; Murphy A; Lin JC; Macdonald LE; Daly C; Sleeman M; Thurston G; Li Z
Sci Adv; 2023 Apr; 9(15):eadf4490. PubMed ID: 37058568
[TBL] [Abstract][Full Text] [Related]
29. Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activation.
Sander LE; Obermeier F; Dierssen U; Kroy DC; Singh AK; Seidler U; Streetz KL; Lutz HH; Müller W; Tacke F; Trautwein C
J Immunol; 2008 Sep; 181(5):3586-94. PubMed ID: 18714032
[TBL] [Abstract][Full Text] [Related]
30. A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control.
Namineni S; O'Connor T; Faure-Dupuy S; Johansen P; Riedl T; Liu K; Xu H; Singh I; Shinde P; Li F; Pandyra A; Sharma P; Ringelhan M; Muschaweckh A; Borst K; Blank P; Lampl S; Neuhaus K; Durantel D; Farhat R; Weber A; Lenggenhager D; Kündig TM; Staeheli P; Protzer U; Wohlleber D; Holzmann B; Binder M; Breuhahn K; Assmus LM; Nattermann J; Abdullah Z; Rolland M; Dejardin E; Lang PA; Lang KS; Karin M; Lucifora J; Kalinke U; Knolle PA; Heikenwalder M
J Hepatol; 2020 May; 72(5):960-975. PubMed ID: 31954207
[TBL] [Abstract][Full Text] [Related]
31. Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease.
Min HK; Mirshahi F; Verdianelli A; Pacana T; Patel V; Park CG; Choi A; Lee JH; Park CB; Ren S; Sanyal AJ
Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(9):G794-803. PubMed ID: 25747354
[TBL] [Abstract][Full Text] [Related]
32. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.
Shigekawa M; Takehara T; Kodama T; Hikita H; Shimizu S; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Hayashi N
Biochem Biophys Res Commun; 2011 Mar; 406(4):614-20. PubMed ID: 21356197
[TBL] [Abstract][Full Text] [Related]
33. Cell type-specific differential induction of the human gamma-fibrinogen promoter by interleukin-6.
Duan HO; Simpson-Haidaris PJ
J Biol Chem; 2006 May; 281(18):12451-7. PubMed ID: 16524883
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of IL-11 promotes premalignant gastric epithelial hyperplasia in isolation from germline gp130-JAK-STAT driver mutations.
Buzzelli JN; O'Connor L; Scurr M; Chung Nien Chin S; Catubig A; Ng GZ; Oshima M; Oshima H; Giraud AS; Sutton P; Judd LM; Menheniott TR
Am J Physiol Gastrointest Liver Physiol; 2019 Feb; 316(2):G251-G262. PubMed ID: 30520693
[TBL] [Abstract][Full Text] [Related]
36. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.
Rose-John S
Int J Biol Sci; 2012; 8(9):1237-47. PubMed ID: 23136552
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice.
Quinton LJ; Blahna MT; Jones MR; Allen E; Ferrari JD; Hilliard KL; Zhang X; Sabharwal V; Algül H; Akira S; Schmid RM; Pelton SI; Spira A; Mizgerd JP
J Clin Invest; 2012 May; 122(5):1758-63. PubMed ID: 22466650
[TBL] [Abstract][Full Text] [Related]
38. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis.
Jenkins BJ; Roberts AW; Greenhill CJ; Najdovska M; Lundgren-May T; Robb L; Grail D; Ernst M
Blood; 2007 Mar; 109(6):2380-8. PubMed ID: 17082315
[TBL] [Abstract][Full Text] [Related]
39. The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.
Xiang DM; Sun W; Ning BF; Zhou TF; Li XF; Zhong W; Cheng Z; Xia MY; Wang X; Deng X; Wang W; Li HY; Cui XL; Li SC; Wu B; Xie WF; Wang HY; Ding J
Gut; 2018 Sep; 67(9):1704-1715. PubMed ID: 28754776
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor.
Dittrich A; Khouri C; Sackett SD; Ehlting C; Böhmer O; Albrecht U; Bode JG; Trautwein C; Schaper F
Hepatology; 2012 Jan; 55(1):256-66. PubMed ID: 21898505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
